07.11.24 -- Where's The Case For Generative AI In Biopharma Manufacturing?

Review our installations in upstream development, downstream development, and fill & finish. Our state-of-the-art EU-GMP certified facility is staffed by a team of 250 professionals and, as of 2023, is focused solely on providing CDMO services to its clients. Capacity is now available and our team is excited to engage in new projects.

The early use cases for AI in the biopharmaceutical industry — at least, the early public use cases — have largely come from R&D, and more specifically, target identification and molecular design. Where are the use cases in biologics manufacturing, supply chain management, QMS, and operations, and what’s holding us back?